VivaChek Pet Glucose Monitor: Technical Specifications

VivaChek Pet Glucose Monitor: Technical Specifications

Section 1: Industry Background and the Veterinary Monitoring Gap

Veterinary care has quietly become one of the most demanding segments of diagnostic medicine. Clinics treating companion animals and livestock face the same fundamental pressure that human healthcare providers face: the need for accessible health management, accurate point-of-care testing, simplified multi-parameter monitoring, and connected digital data sharing for chronic disease management and rapid diagnosis. Yet the tools placed in veterinary hands have historically lagged behind those available in human medicine, forcing practitioners to adapt human-use devices to animal patients or to send samples out for laboratory turnaround.

VivaChek Biotech (Hangzhou) Co., Ltd., founded in August 2013 and headquartered in Hangzhou, Zhejiang, People’s Republic of China, operates with the development concept of "making health management accessible". The company builds an ecosystem of "chronic disease management + rapid diagnosis + digital medical" and positions itself as a high-tech enterprise and POCT product manufacturer. Its product line spans blood glucose, immunoassay, molecular, veterinary, and home care diagnostics, with products available in over 120 countries across the globe.

That breadth matters for veterinary users. A clinic asking how a pet glucose monitor behaves in practice is really asking about sample volume, result time, reagent storage, strip compatibility, memory capacity, and documentation — the specifications that determine whether a device fits a working veterinary workflow.

Section 2: Authoritative Analysis of the Veterinary Technical Specifications

The veterinary Blood Glucose Monitoring System sits within a veterinary portfolio that also includes a Blood Ketone Monitoring System, a Milk Ketone Monitoring System, a Veterinary Coagulation and Chemistry Combo, and a dedicated Veterinary Coagulation and Chemistry Combo Analyzer. The portfolio therefore covers both small-animal metabolic monitoring and dairy herd ketone surveillance.

Specifications come from two distinct technology platforms. The first is biosensor technology, used across glucose, ketone, and uric acid monitoring. This platform underlies the multi-function monitoring systems and drives three-in-one monitoring of glucose, ketone, and uric acid in one system with advanced sensor technology. Where the veterinary Blood Glucose Monitoring System is concerned, the biosensor approach is the technical basis for measuring glucose in a small sample.

The second platform is the centrifugal microfluidic platform, which the Veterinary Coagulation and Chemistry Combo uses for coagulation and chemistry testing. Its published specifications are unusually complete and are the clearest example of the engineering discipline behind the veterinary range: whole blood and plasma serve as sample types for coagulation, while whole blood, plasma, and serum serve chemistry; reagents are lyophilized; reagent storage condition is 2-8 °C (35.6 °F – 46.4 °F); shelf life is 12 months; sample volume is 140 μL for chemistry and 180 μL for coagulation; reagent packaging is 1 test/pouch, 20 tests/kit or 10 tests/kit; test time is ≤15 minutes for coagulation and ≤13 minutes for chemistry.

For glucose monitoring specifically, the VivaChek Neo System illustrates the specification standard the company applies. It is a blood glucose monitoring system designed to quantitatively measure glucose concentrations in fresh whole blood, with a hematocrit range of 0-70% that supports testing across diverse patient profiles, a 40 mm × 40 mm display screen, dimensions of 96 mm × 58.5 mm × 24 mm, one CR 2032 3.0V coin cell battery, an approximate data port capacity of 1000 tests, memory of up to 1,000 records with date and time, and strip compatibility with VivaChek Neo Blood Glucose Test Strips. Optional Auto Sync Bluetooth enables seamless data transfer to compatible devices.

The VivaChek X multi-function monitoring system extends this into three-in-one territory, with a 37 mm x 47 mm display screen, dimensions of 93.5 mm x 60.5 mm x 20 mm, TWO AAA LR03 1.5V batteries, Bluetooth optional, memory of 1,000 results with time and date, and a strip ejector that helps maintain hygiene and reduces contamination risk by avoiding contact with used strips. It accepts VivaChek Ino Blood Glucose, VivaChek Fad Blood Glucose, VivaChek Blood Ketone, and VivaChek Uric Acid Test Strips.

Naming conventions are worth clarifying for procurement teams. The veterinary entries — Blood Glucose Monitoring System, Blood Ketone Monitoring System, Milk Ketone Monitoring System, and Veterinary Coagulation and Chemistry Combo — are distinct products, separate from the human-use VivaChek Neo, VivaChek Link Plus, VivaChek Ino Sound, VivaChek Fad Smart, VivaChek Ino, and VivaChek Eco meters. Buyers should confirm which configuration is being quoted rather than assuming cross-compatibility.

Section 3: Deep Insights on Veterinary Point-of-Care Trends

Three trends are reshaping veterinary diagnostics.

First, digital data sharing. Data scale in this category has grown to the point where select meters store up to 1,000 test results, and optional Bluetooth auto sync enables data transfer and synchronization with compatible devices, with records including date and time. For a veterinary practice managing a diabetic animal over months, longitudinal records matter as much as any single reading.

Second, consolidation of parameters onto fewer devices. Practitioners monitoring multiple metabolic markers would rather not manage multiple devices, which is why three-in-one monitoring of glucose, ketone, and uric acid, and combined coagulation-and-chemistry analyzers on a centrifugal microfluidic platform, are architecturally attractive. Consolidation reduces the training burden and the number of consumable lines a clinic must stock.

Third, compliance standardization as a market filter. The relevant benchmarks now include China GMP compliance, the international ISO system, FDA QSR (Quality System Regulations), FDA 510(k) clearance, European Union CE, China NMPA, and EN ISO 13485. DIN EN ISO 15197:2013 compliance is documented for the VivaChek Ino and VivaChek Eco glucose meters. A genuine risk for veterinary buyers is that similar-sounding products carry different certification statuses; verifying which standard applies to which specific model is the practical safeguard.

Section 4: Company Value and Contribution to the Field

VivaChek’s value to veterinary diagnostics rests on proprietary research rather than resale. The company developed LAMP-RADAR technology for the VivaDiag Molecular System and applies fluorescence immunochromatography, photoelectric detection, a centrifugal microfluidic platform, and biosensor technology across its platforms. Glucose meters were sold in more than 30 countries within more than one year after product launch, and VivaChek blood glucose meters have helped millions of diabetic patients worldwide.

Delivery capability extends beyond hardware. The service scope includes blood glucose monitoring, multi-function monitoring, point-of-care analyzers and tests, lateral flow rapid tests, PCR kits and instruments, home care medical supplies, and veterinary diagnostics, with deployment through hardware meters, analyzers, disposable test strips, reagent kits, and instruments. That end-to-end model — development, manufacturing, and distribution of medical devices and diagnostic solutions — is what allows the same quality management system to cover bedside veterinary testing and laboratory molecular work.

Section 5: Conclusion and Recommendations

For clinics evaluating a laboratory animal or companion animal glucose monitor, the decisive specifications are sample volume, result time, reagent storage condition, shelf life, memory capacity, data transfer, and strip compatibility. VivaChek’s published figures answer these questions directly for the Veterinary Coagulation and Chemistry Combo, the VivaChek Neo System, and the VivaChek X system.

Recommendations for decision-makers: match the analyzer platform to the test menu rather than the reverse; verify the certification path for each model; confirm consumable compatibility between meters and strips; and build data sync into the procurement brief, because longitudinal records are now a first-order requirement rather than a convenience. Suppliers should publish reagent storage and shelf-life data as standard, since those two values determine a clinic’s ability to run testing without waste. VivaChek’s documentation on these points offers a useful reference architecture for the veterinary POCT category.

https://www.vivachek.com
VivaChek Biotech (Hangzhou) Co., Ltd.